Chapelin Named 2021 Scialog Fellow

UK researcher Fanny Chapelin (right) has been named a 2021 Scialog: Advancing Bioimaging Fellow. Photo by UK College of Engineering.
UK researcher Fanny Chapelin (right) has been named a 2021 Scialog: Advancing Bioimaging Fellow. Photo by UK College of Engineering.

LEXINGTON, Ky. (April 30, 2021) — Fanny Chapelin, Ph.D., a research assistant professor in the University of Kentucky College of Engineering’s F. Joseph Halcomb III, M.D. Department of Biomedical Engineering, has been named a 2021 Scialog: Advancing Bioimaging Fellow.

Chapelin is among 55 promising early-career scientists that were selected to participate in this year’s prestigious Research Corporation for Science Advancement program. The series of three yearly meetings will bring together a diverse group of scientists from a wide range of fields to address the challenges involved in enhancing high-resolution imaging of tissues to support basic science and the treatment of disease.

At each conference, participants form multidisciplinary teams to design research projects, which they pitch to a committee of leading scientists who have facilitated discussions throughout the meeting. The committee then recommends seed funding to catalyze the most promising of those team projects, based primarily on the potential for high-impact results.

“It is an honor to be selected as a Scialog Fellow,” Chapelin said. “As an early-stage investigator, focused mentorship from leaders in the field of molecular imaging and networking with fellow bioimagers will be invaluable to grow as an independent researcher.” 

Chapelin’s lab develops non-invasive magnetic resonance imaging (MRI) methods to track immune cell migration to inflammation in different pathologies such as transplant rejection, autoimmune diseases and cancer. The broad aim of the lab is to develop molecular imaging methods to visualize cell therapy tissue distribution, survival and efficacy, and help clinical translation of therapeutic cells by determination of best treatment dosing, schedule and delivery route.

Chapelin has received numerous awards for her achievements in research including France’s “Engineer of the year for science” Award, conferred by l’Usine Nouvelle. She was also recently selected by UK biomedical engineering students for the department’s 2021 Outstanding Teacher Award.

“In her tenure at UK, Chapelin has established herself an exceptional young researcher embarking on a career in translational science empowered by her superb intellectual skills and talent for scientific reasoning,” said Dr. Guigen Zhang, professor and chair of the F. Joseph Halcomb III, M.D. Department of Biomedical Engineering. “She is a well-liked colleague by faculty and staff in the department, the college and beyond. Moreover, she is a well-respected teacher and mentor by students.”

Learn more about Chapelin and her research at


The University of Kentucky is increasingly the first choice for students, faculty and staff to pursue their passions and their professional goals. In the last two years, Forbes has named UK among the best employers for diversity, and INSIGHT into Diversity recognized us as a Diversity Champion four years running. UK is ranked among the top 30 campuses in the nation for LGBTQ* inclusion and safety. UK has been judged a “Great College to Work for" three years in a row, and UK is among only 22 universities in the country on Forbes' list of "America's Best Employers."  We are ranked among the top 10 percent of public institutions for research expenditures — a tangible symbol of our breadth and depth as a university focused on discovery that changes lives and communities. And our patients know and appreciate the fact that UK HealthCare has been named the state’s top hospital for five straight years. Accolades and honors are great. But they are more important for what they represent: the idea that creating a community of belonging and commitment to excellence is how we honor our mission to be not simply the University of Kentucky, but the University for Kentucky.